open access

Vol 9, No 2 (2003)
Original papers
Published online: 2003-03-25
Get Citation

Von Willebrand factor and tissue plasminogen activator as vascular endothelial markers in diabetes type 2

Maria Kotschy, Mirosława Polaszewska-Muszyńska, Wanda Będowska-Gontarz, Zofia Sikorska, Sebastian Moskal
Acta Angiologica 2003;9(2):63-69.

open access

Vol 9, No 2 (2003)
Original papers
Published online: 2003-03-25

Abstract

Background. Vascular endothelium damage can occur in diabetes. During this process endothelial cells release substances known as activity markers. The aim of our study was to determine the concentration of von Willebrand factor (vWf) and tissue plasminogen activator (t-PA) as markers of endothelial cell damage in plasma of diabetics type 2.
Material and methods. The group examined consisted of 60 patients (31 men and 29 women) with diabetes type 2. The mean age was 62 ± 7.9 years, the duration of disease 15 ± 9 years and the mean level of HbA1c 8.76 ± 2.1%. Proliferative retinopathy was observed in 40 patients. All the diabetics were treated with human insulin. The control group consisted of 23 healthy persons aged 48 ± 9 years. The concentration of vWf and t-PA was determined by the ELISA method.
Results. In all type 2 diabetics a significantly higher concentration of von Willebrand factor and tissue plasminogen activator was observed compared with the control group. No differences were noted between diabetics with and without retinopathy. Sex, age, the duration of the diabetes, the concentration of HbA1c and smoking had no significant effect on vWf and t-PA concentrations. In diabetics with coexisting hypertension significantly increased levels of t-PA were noticed.
Conclusion. Increases in vWf and t-PA concentrations indicate vascular endothelial cell damage in type 2 diabetics.

Abstract

Background. Vascular endothelium damage can occur in diabetes. During this process endothelial cells release substances known as activity markers. The aim of our study was to determine the concentration of von Willebrand factor (vWf) and tissue plasminogen activator (t-PA) as markers of endothelial cell damage in plasma of diabetics type 2.
Material and methods. The group examined consisted of 60 patients (31 men and 29 women) with diabetes type 2. The mean age was 62 ± 7.9 years, the duration of disease 15 ± 9 years and the mean level of HbA1c 8.76 ± 2.1%. Proliferative retinopathy was observed in 40 patients. All the diabetics were treated with human insulin. The control group consisted of 23 healthy persons aged 48 ± 9 years. The concentration of vWf and t-PA was determined by the ELISA method.
Results. In all type 2 diabetics a significantly higher concentration of von Willebrand factor and tissue plasminogen activator was observed compared with the control group. No differences were noted between diabetics with and without retinopathy. Sex, age, the duration of the diabetes, the concentration of HbA1c and smoking had no significant effect on vWf and t-PA concentrations. In diabetics with coexisting hypertension significantly increased levels of t-PA were noticed.
Conclusion. Increases in vWf and t-PA concentrations indicate vascular endothelial cell damage in type 2 diabetics.
Citation Formats

Keywords

von Willebrand factor; tissue plasminogen activator; diabetes type 2

About this article
Title

Von Willebrand factor and tissue plasminogen activator as vascular endothelial markers in diabetes type 2

Journal

Acta Angiologica

Issue

Vol 9, No 2 (2003)

Pages

63-69

Published online

2003-03-25

Bibliographic record

Acta Angiologica 2003;9(2):63-69.

Keywords

von Willebrand factor
tissue plasminogen activator
diabetes type 2

Authors

Maria Kotschy
Mirosława Polaszewska-Muszyńska
Wanda Będowska-Gontarz
Zofia Sikorska
Sebastian Moskal

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl